当前位置:首页 - 行情中心 - 海王生物(000078) - 财务分析 - 现金流量表

海王生物

(000078)

  

流通市值:70.13亿  总市值:70.25亿
流通股本:26.26亿   总股本:26.31亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金14,100,111,719.337,064,334,275.2134,506,994,702.725,280,609,010.7
  收到的税费返还3,885,538.77221,332.72764,515.968,478,644.79
  收到其他与经营活动有关的现金2,126,537,819.211,345,335,528.92,429,015,566.722,784,648,753.99
  经营活动现金流入小计16,230,535,077.318,409,891,136.8336,936,774,785.3828,073,736,409.48
  购买商品、接受劳务支付的现金12,115,217,351.236,058,772,313.0231,554,444,677.2623,478,933,862.88
  支付给职工以及为职工支付的现金493,335,319.32268,541,180.571,020,405,486.9751,736,458.27
  支付的各项税费311,966,805.19148,439,657.33718,624,669.72562,528,819.13
  支付其他与经营活动有关的现金3,251,934,203.91,886,706,674.723,603,760,143.243,229,869,197.51
  经营活动现金流出小计16,172,453,679.648,362,459,825.6436,897,234,977.1228,023,068,337.79
  经营活动产生的现金流量净额58,081,397.6747,431,311.1939,539,808.2650,668,071.69
二、投资活动产生的现金流量:
  收回投资收到的现金19,582,769.9219,356,592.58868,063,284.61301,506,555
  取得投资收益收到的现金688,000643,317.457,333,555.567,410,885.09
  处置固定资产、无形资产和其他长期资产收回的现金净额5,219,607.532,392,759.187,622,706.245,034,840.6
  处置子公司及其他营业单位收到的现金净额6,703,608.79-13,986,533.7829,131,539.09
  收到的其他与投资活动有关的现金--552,100-
  投资活动现金流入小计32,193,986.2422,392,669.21897,558,180.19343,083,819.78
  购建固定资产、无形资产和其他长期资产支付的现金86,544,612.3962,522,838.4684,601,674.285,972,045.96
  投资支付的现金20,036,90316,030,703909,225,289.33284,315,000
  取得子公司及其他营业单位支付的现金--43,959,190.7135,370,690.71
  支付其他与投资活动有关的现金-15,665,259.51-0
  投资活动现金流出小计106,581,515.3994,218,800.971,037,786,154.24405,657,736.67
  投资活动产生的现金流量净额-74,387,529.15-71,826,131.76-140,227,974.05-62,573,916.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,000,0002,000,00017,000,00011,200,000
  其中:子公司吸收少数股东投资收到的现金2,000,0002,000,00017,000,00011,200,000
  取得借款收到的现金3,542,058,226.072,442,308,798.9610,812,039,695.556,625,300,260.57
  收到其他与筹资活动有关的现金4,642,733,105.342,703,972,985.379,138,843,937.514,619,851,267.93
  筹资活动现金流入小计8,186,791,331.415,148,281,784.3319,967,883,633.0611,256,351,528.5
  偿还债务支付的现金3,577,221,874.52,408,941,811.6312,257,193,276.786,620,879,765.09
  分配股利、利润或偿付利息支付的现金297,405,156.48136,646,141.91697,349,346.6511,374,807.32
  其中:子公司支付给少数股东的股利、利润75,886,964.3528,347,366.78190,709,540.02123,795,948.83
  支付其他与筹资活动有关的现金4,443,393,282.152,866,013,452.86,776,787,950.664,450,157,540.89
  筹资活动现金流出小计8,318,020,313.135,411,601,406.3419,731,330,574.0411,582,412,113.3
  筹资活动产生的现金流量净额-131,228,981.72-263,319,622.01236,553,059.02-326,060,584.8
四、汇率变动对现金及现金等价物的影响-359.1--358.97
五、现金及现金等价物净增加额-147,535,472.3-287,714,442.58135,864,893.23-337,966,071.03
  加:期初现金及现金等价物余额1,272,594,941.511,272,594,941.511,136,730,048.281,136,730,048.28
  期末现金及现金等价物余额1,125,059,469.21984,880,498.931,272,594,941.51798,763,977.25
补充资料:
  净利润64,822,903.73--1,167,311,201.03-
  资产减值准备-2,809,693.07-811,871,188.17-
  固定资产和投资性房地产折旧49,189,245.02-133,572,829.85-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧49,189,245.02-133,572,829.85-
  无形资产摊销17,573,339.63-34,174,183.8-
  长期待摊费用摊销10,146,980.15-20,234,067.04-
  处置固定资产、无形资产和其他长期资产的损失173,310.51--6,808,511.29-
  固定资产报废损失--0-
  公允价值变动损失-70,959.24--6,384,310.59-
  财务费用297,658,906.22-808,767,253.27-
  投资损失-88,840,372.84--11,147,013.77-
  递延所得税24,024,244.76--51,994,768.44-
  其中:递延所得税资产减少24,457,207.18--51,128,090.56-
    递延所得税负债增加-432,962.42--866,677.88-
  存货的减少128,671,270.01-163,279,414.2-
  经营性应收项目的减少-316,381,161.99-554,789,797.68-
  经营性应付项目的增加-157,300,329.87--1,321,199,871.11-
  其他--0-
  不涉及现金收支的投资和筹资活动金额其他项目--71,080,431.63-
  现金的期末余额1,125,059,469.21-1,272,594,941.51-
  减:现金的期初余额1,272,594,941.51-1,136,730,048.28-
  现金及现金等价物的净增加额-147,535,472.3-135,864,893.23-
公告日期2025-08-302025-04-292025-04-292024-10-31
审计意见(境内)标准无保留意见
TOP↑